Hyperliquid Strategies Inc
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Hyperliquid Strategies Inc
Sonnet BioTherapeutics Holdings, Inc. was incorporated in Delaware on October 21, 1999. The company is a clinical-stage biopharmaceutical firm leveraging its proprietary FHAB (Fully Human Albumin-Binding) platform to develop novel biologic therapies. FHAB technology combines fully human single-chain antibody fragments (scFvs) with one or two therapeutic payloads, enabling either single or dual-targeting mechanisms of action. A key feature of the FHAB design is a specialized domain that binds to human serum albumin (HSA), effectively 'hitching a ride' through the bloodstream to reach target sites such as solid tumors or lymphatic tissues. This approach enhances drug accumulation in specific tissues while extending the duration of therapeutic activity in the body. FHAB-based candidates are produced in mammalian cell cultures, allowing for natural glycosylation patterns that help minimize immunogenicity risks. With its versatile and innovative platform, Sonnet BioTherapeutics is well-positioned to advance treatments across a range of human diseases, including oncology, autoimmune disorders, infectious diseases, inflammation, and hematology. Company website: http://www.sonnetbio.com Company address: 100 Overlook Center Suite 102 Princeton NJ 08540
How to Buy Hyperliquid Strategies Inc (PURR)
Sign In
1-Minute Account Opening
Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.
Deposit funds
Once your account has been verified, you can deposit funds into your account using your preferred payment method.
Buy PURR
Search for PURR via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.